STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

TKPHF Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 121.2M shares, representing 7.7% of TAKEDA PHARMACEUTICAL CO LTD in this filing.

FiledFeb 6, 2024
Ownership dateDec 31, 2023
Reported shares121.2M
Reported ownership7.7%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 121.2M
Shared voting power 121.2M
Sole dispositive power 121.2M
Shared dispositive power 121.2M
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$27.51as of Feb 6, 2024
Latest tracked price$35.89as of Aug 3, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
BlackRock
CIK
CIK0001364742
Accession
0001086364-24-006590
Form
Schedule 13G/A
Open SEC filing View TKPHF ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →